Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
4.880
-0.140 (-2.79%)
At close: Oct 7, 2026, 4:00 PM EDT
4.800
-0.080 (-1.64%)
After-hours: Oct 7, 2026, 7:30 PM EDT
Psyence Biomedical Employees
Psyence Biomedical had 12 employees as of March 31, 2025. That makes Psyence Biomedical the world's 39,677th largest employer and 5,963rd in the United States.
Employees
12
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$578,035
Market Cap
18.61M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 138 |
| Palatin Technologies | 29 |
| Jasper Therapeutics | 22 |
| Lipocine | 14 |
| Actuate Therapeutics | 12 |
| Cocrystal Pharma | 10 |
| Akari Therapeutics, | 6 |
| Marker Therapeutics | 5 |
PBM News
- 2 days ago - Psyence Biomedical teams with Benuvia to establish U.S. manufacture of ibogaine - TheFly
- 2 days ago - Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine - GlobeNewsWire
- 9 days ago - Psyence Biomedical announces exclusive U.S. Ibogaine license for TIRC - TheFly
- 9 days ago - Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation - GlobeNewsWire
- 14 days ago - Psyence Biomedical announces strategic Ibogaine investment - TheFly
- 14 days ago - Psyence BioMed Announces Strategic Ibogaine Investment - GlobeNewsWire
- 23 days ago - Psyence Biomedical establishes Texas Ibogaine Research Corporation - TheFly
- 23 days ago - Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development - GlobeNewsWire